文献速递物质与行为成瘾

阿片类物质使用障碍个体化6个月死亡风险预测模型

Prediction of individualised 6-month mortality risk in opioid use disorder.
PubMed 文献 · Br J Psychiatry · 2025-07-07

本研究基于英格兰成瘾治疗、住院和死亡记录(2013年4月1日至2022年4月1日),开发并内部验证了首个预测阿片类物质使用障碍(OUD)患者6个月全因和药物相关死亡风险的预后模型。研究纳入236 064名OUD患者,期间发生2427例全因死亡(其中1289例为药物相关死亡)。两个最终模型均显示出良好的乐观校正区分度和校准度,全因和药物相关模型的Harrell C统计量分别为0.73(95%CI 0.71-0.75)和0.74(95%CI 0.72-0.76)。

要点

  • 基于常规收集的成瘾治疗基线指标,可个体化预测OUD患者6个月全因和药物相关死亡风险。
  • 全因死亡模型Harrell C为0.73(95%CI 0.71-0.75),药物相关死亡模型为0.74(95%CI 0.72-0.76)。
  • 模型仅完成内部验证,需独立外部验证后方可用于政策与临床决策。

核心结论

  • 开发并内部验证了Roberts OUD死亡风险模型,为首个能准确量化成瘾服务中OUD患者个体化6个月绝对死亡风险的模型。

研究设计与样本

  • 利用英格兰全国链接的成瘾治疗、住院和死亡记录(2013年4月1日至2022年4月1日),纳入236 064名OUD患者。
  • 从13个候选预后变量(社会人口学、注射状态、健康和心理健康因素)构建多变量Cox回归模型,连续变量采用分数多项式方法,缺失数据用链式方程多重插补处理。
  • 采用bootstrapping方法进行内部验证,以Harrell C和D统计量、观察与预测事件率及校准曲线斜率评估区分度和校准度。

主要发现

  • 共发生2427例全因死亡,其中1289例为药物相关死亡。
  • 全因死亡模型Harrell C为0.73(95%CI 0.71-0.75),D统计量为1.01(95%CI 0.95-1.08),校准斜率为1.01(95%CI 0.95-1.08)。
  • 药物相关死亡模型Harrell C为0.74(95%CI 0.72-0.76),D统计量为1.07(95%CI 0.98-1.16),校准斜率为1.01(95%CI 0.94-1.10)。
  • 两个最终模型均表现出良好的乐观校正区分度和校准度。

临床怎么用

  • 模型可用于成瘾治疗服务中基于基线评估指标个体化量化OUD患者6个月全因和药物相关死亡风险。
  • 在独立外部验证完成前,模型可辅助未来政策、委托和临床决策,但需谨慎解读个体化风险。

局限性

  • 模型仅完成内部验证(bootstrapping),作者明确指出需独立验证以确保模型在更广泛未来政策、委托和临床决策中的最佳效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with opioid use disorder (OUD) have substantially higher standardised mortality rates compared with the general population. However, lack of individualised prognostic information presents challenges in personalisation of addiction treatment delivery. AIMS: To develop and validate the first prognostic models to estimate 6-month all-cause and drug-related mortality risk for people diagnosed with OUD using indicators recorded at baseline assessment in addiction services in England. METHOD: Thirteen candidate prognostic variables, including sociodemographic, injecting status and health and mental health factors, were identified from nationally linked addiction treatment, hospital admission and death records from 1 April 2013 to 1 April 2022. Multivariable Cox regression models were developed with a fractional polynomial approach for continuous variables, and missing data were addressed using multiple imputation by chained equations. Validation was undertaken using bootstrapping methods. Discrimination was assessed using Harrel's C and D statistics alongside examination of observed-to-predicted event rates and calibration curve slopes. RESULTS: Data were available for 236 064 people with OUD, with 2427 deaths due to any cause, including 1289 due to drug-related causes. Both final models demonstrated good optimism-adjusted discrimination and calibration, with all-cause and drug-related models, respectively, demonstrating Harrell's C statistics of 0.73 (95% CI 0.71-0.75) and 0.74 (95% CI 0.72-0.76), D-statistics of 1.01 (95% CI 0.95-1.08) and 1.07 (95% CI 0.98-1.16) and calibration slopes of 1.01 (95% CI 0.95-1.08) and 1.01 (95% CI 0.94-1.10). CONCLUSIONS: We developed and internally validated Roberts' OUD mortality risk, with the first models to accurately quantify individualised absolute 6-month mortality risks in people with OUD presenting to addiction services. Independent validation is warranted to ensure these models have the optimal utility to assist wider future policy, commissioning and clinical decision-making.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Roberts E, Strang J, Taylor E, et al. Prediction of individualised 6-month mortality risk in opioid use disorder. Br J Psychiatry. 2025. PMID: 40619917. doi:10.1192/bjp.2025.10313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。